Literature DB >> 15298872

Reversible aggregation plays a crucial role on the folding landscape of p53 core domain.

Daniella Ishimaru1, Luis M T R Lima, Lenize F Maia, Priscila M Lopez, Ana P Ano Bom, Ana P Valente, Jerson L Silva.   

Abstract

The role of tumor suppressor protein p53 in cell cycle control depends on its flexible and partially unstructured conformation, which makes it crucial to understand its folding landscape. Here we report an intermediate structure of the core domain of the tumor suppressor protein p53 (p53C) during equilibrium and kinetic folding/unfolding transitions induced by guanidinium chloride. This partially folded structure was undetectable when investigated by intrinsic fluorescence. Indeed, the fluorescence data showed a simple two-state transition. On the other hand, analysis of far ultraviolet circular dichroism in 1.0 M guanidinium chloride demonstrated a high content of secondary structure, and the use of an extrinsic fluorescent probe, 4,4'-dianilino-1,1' binaphthyl-5,5'-disulfonic acid, indicated an increase in exposure of the hydrophobic core at 1 M guanidinium chloride. This partially folded conformation of p53C was plagued by aggregation, as suggested by one-dimensional NMR and demonstrated by light-scattering and gel-filtration chromatography. Dissociation by high pressure of these aggregates reveals the reversibility of the process and that the aggregates have water-excluded cavities. Kinetic measurements show that the intermediate formed in a parallel reaction between unfolded and folded structures and that it is under fine energetic control. They are not only crucial to the folding pathway of p53C but may explain as well the vulnerability of p53C to undergo departure of the native to an inactive state, which makes the cell susceptible to malignant transformation. Copyright 2004 Biophysical Society

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15298872      PMCID: PMC1304688          DOI: 10.1529/biophysj.104.044685

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  48 in total

Review 1.  Protein misfolding, evolution and disease.

Authors:  C M Dobson
Journal:  Trends Biochem Sci       Date:  1999-09       Impact factor: 13.807

2.  Intermediates can accelerate protein folding.

Authors:  C Wagner; T Kiefhaber
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

3.  Mechanism of folding and assembly of a small tetrameric protein domain from tumor suppressor p53.

Authors:  M G Mateu; M M Sánchez Del Pino; A R Fersht
Journal:  Nat Struct Biol       Date:  1999-02

Review 4.  MDM2--arbiter of p53's destruction.

Authors:  D P Lane; P A Hall
Journal:  Trends Biochem Sci       Date:  1997-10       Impact factor: 13.807

Review 5.  From Levinthal to pathways to funnels.

Authors:  K A Dill; H S Chan
Journal:  Nat Struct Biol       Date:  1997-01

Review 6.  How important is the molten globule for correct protein folding?

Authors:  T E Creighton
Journal:  Trends Biochem Sci       Date:  1997-01       Impact factor: 13.807

7.  Thermodynamic stability of wild-type and mutant p53 core domain.

Authors:  A N Bullock; J Henckel; B S DeDecker; C M Johnson; P V Nikolova; M R Proctor; D P Lane; A R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

Review 8.  The p53 pathway.

Authors:  C Prives; P A Hall
Journal:  J Pathol       Date:  1999-01       Impact factor: 7.996

9.  Characterization of a partially folded monomer of the DNA-binding domain of human papillomavirus E2 protein obtained at high pressure.

Authors:  D Foguel; J L Silva; G de Prat-Gay
Journal:  J Biol Chem       Date:  1998-04-10       Impact factor: 5.157

10.  A transient expansion of the native state precedes aggregation of recombinant human interferon-gamma.

Authors:  B S Kendrick; J F Carpenter; J L Cleland; T W Randolph
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

View more
  15 in total

Review 1.  Disorder-to-order conformational transitions in protein structure and its relationship to disease.

Authors:  Paola Mendoza-Espinosa; Victor García-González; Abel Moreno; Rolando Castillo; Jaime Mas-Oliva
Journal:  Mol Cell Biochem       Date:  2009-04-09       Impact factor: 3.396

2.  p53 protein aggregation promotes platinum resistance in ovarian cancer.

Authors:  Y Yang-Hartwich; M G Soteras; Z P Lin; J Holmberg; N Sumi; V Craveiro; M Liang; E Romanoff; J Bingham; F Garofalo; A Alvero; G Mor
Journal:  Oncogene       Date:  2014-09-29       Impact factor: 9.867

3.  Distinct modulatory role of RNA in the aggregation of the tumor suppressor protein p53 core domain.

Authors:  Petar Stefanov Kovachev; Debapriya Banerjee; Luciana Pereira Rangel; Jonny Eriksson; Murilo M Pedrote; Mafalda Maria D C Martins-Dinis; Katarina Edwards; Yraima Cordeiro; Jerson L Silva; Suparna Sanyal
Journal:  J Biol Chem       Date:  2017-04-18       Impact factor: 5.157

Review 4.  Aggregation and Prion-Like Properties of Misfolded Tumor Suppressors: Is Cancer a Prion Disease?

Authors:  Danielly C F Costa; Guilherme A P de Oliveira; Elio A Cino; Iaci N Soares; Luciana P Rangel; Jerson L Silva
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-10-03       Impact factor: 10.005

5.  The (1-63) region of the p53 transactivation domain aggregates in vitro into cytotoxic amyloid assemblies.

Authors:  Stefania Rigacci; Monica Bucciantini; Annalisa Relini; Alessandra Pesce; Alessandra Gliozzi; Andrea Berti; Massimo Stefani
Journal:  Biophys J       Date:  2008-01-16       Impact factor: 4.033

6.  Mutant p53 aggregates into prion-like amyloid oligomers and fibrils: implications for cancer.

Authors:  Ana P D Ano Bom; Luciana P Rangel; Danielly C F Costa; Guilherme A P de Oliveira; Daniel Sanches; Carolina A Braga; Lisandra M Gava; Carlos H I Ramos; Ana O T Cepeda; Ana C Stumbo; Claudia V De Moura Gallo; Yraima Cordeiro; Jerson L Silva
Journal:  J Biol Chem       Date:  2012-06-19       Impact factor: 5.157

Review 7.  Expanding the prion concept to cancer biology: dominant-negative effect of aggregates of mutant p53 tumour suppressor.

Authors:  Jerson L Silva; Luciana P Rangel; Danielly C F Costa; Yraima Cordeiro; Claudia V De Moura Gallo
Journal:  Biosci Rep       Date:  2013-07-25       Impact factor: 3.840

Review 8.  Misfolding, Aggregation, and Disordered Segments in c-Abl and p53 in Human Cancer.

Authors:  Guilherme A P de Oliveira; Luciana P Rangel; Danielly C Costa; Jerson L Silva
Journal:  Front Oncol       Date:  2015-04-29       Impact factor: 6.244

9.  The p53 core domain is a molten globule at low pH: functional implications of a partially unfolded structure.

Authors:  Ana Paula D Ano Bom; Monica S Freitas; Flavia S Moreira; Danielly Ferraz; Daniel Sanches; Andre M O Gomes; Ana Paula Valente; Yraima Cordeiro; Jerson L Silva
Journal:  J Biol Chem       Date:  2009-11-17       Impact factor: 5.157

Review 10.  Ligand binding and hydration in protein misfolding: insights from studies of prion and p53 tumor suppressor proteins.

Authors:  Jerson L Silva; Tuane C R G Vieira; Mariana P B Gomes; Ana Paula Ano Bom; Luis Mauricio T R Lima; Monica S Freitas; Daniella Ishimaru; Yraima Cordeiro; Debora Foguel
Journal:  Acc Chem Res       Date:  2010-02-16       Impact factor: 22.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.